Splet08. dec. 2024 · On December 8, 2024, PDL BioPharma, Inc. (the "Company") delivered formal notice to The Nasdaq Stock Market, Inc. that the Company intends to voluntarily delist its common stock, par value $0.01 per share (the "Common Stock"), from the Nasdaq Global Stock Market ("Nasdaq") in connection with the Company's previously disclosed … SpletPdl Biopharma, Inc. CIK: 882104 Ticker: PDLI GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies
Document - SEC
Splet04. dec. 2024 · pdli-20241204 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the … SpletThe following Q&A is intended to help answer questions about the delisting of the PDL BioPharma, Inc.’s (“PDL” or the “Company”) stock and Plan of Dissolution. ... PDL filed a … topi pooq
Pdl Biopharma, Inc. – Filings and Transcripts – BamSEC
Splet哪里可以找行业研究报告?三个皮匠报告网的最新栏目每日会更新大量报告,包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新,通过最新栏目,大家可以快速找到自己想要的内容 … SpletOn February 27, 2024, PDL BioPharma, Inc., a Delaware corporation (the “Company”), entered into a cooperation and support agreement (the “Agreement”) with Engine Capital, … SpletPDL BioPharma, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: topi plastik